blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0211502

EP0211502 - Use of metabolites of linoleic or linolenic acid in the treatment of premenstrual syndrome [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  30.07.1992
Database last updated on 03.09.2024
Most recent event   Tooltip30.07.1992No opposition filed within time limitpublished on 16.09.1992 [1992/38]
Applicant(s)For all designated states
EFAMOL HOLDINGS PLC
Efamol House Woodbridge Meadows Guildford
Surrey GU1 1BA / GB
[N/P]
Former [1991/15]For all designated states
EFAMOL HOLDINGS PLC
Efamol House Woodbridge Meadows
Guildford Surrey GU1 1BA / GB
Former [1987/09]For all designated states
EFAMOL LIMITED
Efamol House Woodbridge Meadows
Guildford Surrey GU1 1BA / GB
Inventor(s)01 / Horrobin, David Frederick
c/o Efamol Limited Efamol House Woodbridge Meadows
Guildford Surrey, GU1 1BA / GB
[1987/09]
Representative(s)Miller, Joseph, et al
J. MILLER & CO. 34 Bedford Row, Holborn
London WC1R 4JH / GB
[1991/35]
Former [1987/09]Caro, William Egerton
J. MILLER & CO. Lincoln House 296-302 High Holborn
London WC1V 7JH / GB
Application number, filing date86304860.924.06.1986
[1987/09]
Priority number, dateGB1985001690604.07.1985         Original published format: GB 8516906
[1987/09]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0211502
Date:25.02.1987
Language:EN
[1987/09]
Type: A3 Search report 
No.:EP0211502
Date:18.01.1989
Language:EN
[1989/03]
Type: B1 Patent specification 
No.:EP0211502
Date:25.09.1991
Language:EN
[1991/39]
Search report(s)(Supplementary) European search report - dispatched on:EP29.11.1988
ClassificationIPC:A61K31/20, A61K31/16, A61K31/23
[1987/09]
CPC:
A61K31/20 (EP); A61K31/16 (EP); A61K31/23 (EP);
A61P13/02 (EP); A61P15/00 (EP); A61P25/04 (EP)
Designated contracting statesAT,   BE,   CH,   DE,   FR,   GB,   IT,   LI,   LU,   NL,   SE [1987/09]
TitleGerman:Verwendung von Linol- oder Linolensäure-Metaboliten zur Behandlung vom prämenstruellen Syndrom[1987/09]
English:Use of metabolites of linoleic or linolenic acid in the treatment of premenstrual syndrome[1987/09]
French:Utilisation des métabolites de l'acide linoléique ou linolénique pour le traitement du syndrome prémenstruel[1987/09]
Examination procedure26.04.1989Examination requested  [1989/27]
26.04.1990Despatch of a communication from the examining division (Time limit: M04)
14.07.1990Reply to a communication from the examining division
04.09.1990Despatch of communication of intention to grant (Approval: No)
22.11.1990Despatch of communication of intention to grant (Approval: later approval)
17.12.1990Communication of intention to grant the patent
11.02.1991Fee for grant paid
11.02.1991Fee for publishing/printing paid
Opposition(s)26.06.1992No opposition filed within time limit [1992/38]
Fees paidRenewal fee
18.05.1988Renewal fee patent year 03
05.05.1989Renewal fee patent year 04
08.05.1990Renewal fee patent year 05
25.06.1991Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]EP0003407  (EFAMOL LTD [GB]);
 [X]EP0181689  (EFAMOL LTD [GB])
 [A]  - R.BERKOW et al.: "THE MERCK MANUAL OF DIAGNOSIS AND THERAPY", 1987, 15th edition, pages 1710-1711, Merck & Co., Inc., Rahway, N.J., US
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.